Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

432.72
Delayed Data
As of Sep 22
 -0.73 / -0.17%
Today’s Change
325.35
Today|||52-Week Range
543.55
+17.88%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 495.50, with a high estimate of 605.00 and a low estimate of 408.00. The median estimate represents a +14.51% increase from the last price of 432.72.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.83
Sales
$1.5B
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.21%
 
 
 
 
 
 
Growthannually 31.36%
 
 
 
 
 
 

Sales

Growthquarterly -1.00%
 
 
 
 
 
 
Growthannually 18.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.